91 related articles for article (PubMed ID: 8339303)
1. [The effects of chronic cilazapril treatment on sympathetic vasomotor tonus: a spectral analysis study of pressure variability].
Pagani M; Lucini D; Pizzinelli P; Brera V; Sommariva D; Di Michele R; Malliani A
Cardiologia; 1993 Mar; 38(3):149-56. PubMed ID: 8339303
[TBL] [Abstract][Full Text] [Related]
2. Modulation of sympathetic vasomotor control with cilazapril in mild hypertension.
Pagani M; Lucini D; Pizzinelli P; Mariani P; Di Michele R; Malliani A
Am J Med; 1993 Apr; 94(4A):55S-58S. PubMed ID: 8488861
[No Abstract] [Full Text] [Related]
3. Evidence of increased sympathetic vasomotor drive with shorter acting dihydropyridine calcium channel antagonists in human hypertension: a study using spectral analysis of RR interval and systolic arterial pressure variability.
Lucini D; Mela GS; Malliani A; Pagani M
J Cardiovasc Pharmacol; 1997 May; 29(5):676-83. PubMed ID: 9213212
[TBL] [Abstract][Full Text] [Related]
4. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition.
Tank J; Schroeder C; Diedrich A; Szczech E; Haertter S; Sharma AM; Luft FC; Jordan J
Circulation; 2003 Jun; 107(23):2949-54. PubMed ID: 12796139
[TBL] [Abstract][Full Text] [Related]
5. [Spontaneous baroreflex control of heart rate during chronic tandropril therapy].
Raimondi G; Iellamo F; Legramante JM; Massaro M; Cassarino S; Micozzi F; Peruzzi G
Cardiologia; 1998 Apr; 43(4):395-401. PubMed ID: 9659797
[TBL] [Abstract][Full Text] [Related]
6. Impaired sympathetic response before intradialytic hypotension: a study based on spectral analysis of heart rate and pressure variability.
Pelosi G; Emdin M; Carpeggiani C; Morales MA; Piacenti M; Dattolo P; Cerrai T; Macerata A; L'abbate A; Maggiore Q
Clin Sci (Lond); 1999 Jan; 96(1):23-31. PubMed ID: 9857103
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the sympathetic nervous system using heart rate variability and plasma hormones in hypertensive patients treated with cilazapril and atenolol.
Campelo M; Polónia J; Serrão P; Cerqueira-Gomes M
Cardiology; 1996; 87(5):402-8. PubMed ID: 8894261
[TBL] [Abstract][Full Text] [Related]
8. Effects of chronic cilazapril treatment on cardiovascular control: a spectral analytical approach.
Pagani M; Pizzinelli P; Mariani P; Lucini D; di Michele R; Malliani A
J Cardiovasc Pharmacol; 1992; 19 Suppl 6():S110-6. PubMed ID: 1382158
[TBL] [Abstract][Full Text] [Related]
9. Effects of moderate salt restriction alone and in combination with cilazapril on office and ambulatory blood pressure.
Uusitupa M; Korhonen M; Litmanen H; Niskanen L; Väisänen S; Rauramaa R
J Hum Hypertens; 1996 May; 10(5):319-26. PubMed ID: 8817406
[TBL] [Abstract][Full Text] [Related]
10. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
Yasuda G; Hasegawa K; Kuji T; Ogawa N; Shimura G; Umemura S; Tochikubo O
Diabet Med; 2005 Oct; 22(10):1394-400. PubMed ID: 16176202
[TBL] [Abstract][Full Text] [Related]
11. Sympathetic activity, assessed by power spectral analysis of heart rate variability, in white-coat, masked and sustained hypertension versus true normotension.
Fagard RH; Stolarz K; Kuznetsova T; Seidlerova J; Tikhonoff V; Grodzicki T; Nikitin Y; Filipovsky J; Peleska J; Casiglia E; Thijs L; Staessen JA; Kawecka-Jaszcz K
J Hypertens; 2007 Nov; 25(11):2280-5. PubMed ID: 17921823
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of the effects of the angiotensin converting enzyme inhibitor cilazapril on diurnal blood pressure.
Nakanishi T; Takahashi H; Nishimura M; Yoshimura M
Clin Ther; 1993; 15(2):294-303. PubMed ID: 8519038
[TBL] [Abstract][Full Text] [Related]
13. A controlled study of the autonomic changes produced by habitual cigarette smoking in healthy subjects.
Lucini D; Bertocchi F; Malliani A; Pagani M
Cardiovasc Res; 1996 Apr; 31(4):633-9. PubMed ID: 8689656
[TBL] [Abstract][Full Text] [Related]
14. Effects of short-term hypocaloric diet on sympatho-vagal interaction assessed by spectral analysis of heart rate and blood pressure variability during stress tests in obese hypertensive patients.
Ashida T; Ono C; Sugiyama T
Hypertens Res; 2007 Dec; 30(12):1199-203. PubMed ID: 18344625
[TBL] [Abstract][Full Text] [Related]
15. Effects of dipeptidyl peptidase iv inhibition on arterial blood pressure.
Jackson EK; Dubinion JH; Mi Z
Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):29-34. PubMed ID: 18047624
[TBL] [Abstract][Full Text] [Related]
16. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
[TBL] [Abstract][Full Text] [Related]
17. Dissociation between microneurographic and heart rate variability estimates of sympathetic tone in normal subjects and patients with heart failure.
Notarius CF; Butler GC; Ando S; Pollard MJ; Senn BL; Floras JS
Clin Sci (Lond); 1999 Jun; 96(6):557-65. PubMed ID: 10334961
[TBL] [Abstract][Full Text] [Related]
18. [Effect of cilazapril in patients with essential hypertension: effect on cardiac hypertrophy].
Abrahám G; Pogátsa-Murray G; Forster T; Csanády M; Sonkodi S
Orv Hetil; 1996 Jul; 137(29):1583-6. PubMed ID: 8757070
[TBL] [Abstract][Full Text] [Related]
19. Cyclosporine-induced hypertension: evidence for maintained baroreflex circulatory control.
Lucini D; Milani RV; Ventura HO; Mehra MR; Messerli FH; Murgo JP; Regenstein F; Copley B; Malliani A; Pagani M
J Heart Lung Transplant; 1997 Jun; 16(6):615-20. PubMed ID: 9229291
[TBL] [Abstract][Full Text] [Related]
20. [Hemodynamic effects of chronic treatment by cilazapril in normotensive patients with obliterative arterial diseases of the lower limbs].
Laurent S; Becquemont L; Laloux B; Asmar R; Hugue C; Vayssairat M; Billaud E; Bauthier P; Cohen N; Houri L
Arch Mal Coeur Vaiss; 1994 Aug; 87(8):987-90. PubMed ID: 7755478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
